US HB8855 | 2021-2022 | 117th Congress

Status

Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on September 15 2022 - 25% progression, died in committee
Action: 2022-09-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To establish a program to address sickle cell disease and other heritable hemoglobinopathies.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Sickle Cell Disease Treatment Centers Act of 2022

Sponsors


History

DateChamberAction
2022-09-16HouseReferred to the Subcommittee on Health.
2022-09-15HouseReferred to the House Committee on Energy and Commerce.
2022-09-15HouseIntroduced in House

Same As/Similar To

SB4866 (Same As) 2022-09-15 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback